Explore: Sclerosing Cholangitis

Primary sclerosing cholangitis (PSC) is a long-term progressive disease of the liver and gallbladder characterized by inflammation and scarring of the

has been clearly demonstrated that sclerosing cholangitis can develop after an episode of severe bacterial cholangitis. Also it was suggested that it can

Ascending cholangitis, also known as acute cholangitis or simply cholangitis, is inflammation of the bile duct, usually caused by bacteria ascending from

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. It results from a slow, progressive

primary sclerosing cholangitis have ulcerative colitis. As many as 5% of people with UC may progress to develop primary sclerosing cholangitis. PSC is more

prominently than others. Some rare causes include primary sclerosing cholangitis, primary biliary cholangitis, familial intrahepatic cholestasis, Alagille syndrome

status. WHO Drug Information advises against its use in primary sclerosing cholangitis in unapproved doses beyond 13–15 mg/kg/day. UDCA in a dose of 28–30 mg/kg/day

ampulla of Vater. Risk factors for cholangiocarcinoma include primary sclerosing cholangitis (an inflammatory disease of the bile ducts), ulcerative colitis

Neonatal ichthyosis–sclerosing cholangitis syndrome (also known as "NISCH syndrome" and "ichthyosis–sclerosing cholangitis syndrome") is a cutaneous condition

primary sclerosing cholangitis, a type of inflammation of the bile ducts. Specifically, 0.96% of people with Crohn's disease also have primary sclerosing cholangitis